ITT Completes Acquisition Of Hartzell Aerospace
Tahoe Resources And Rio Alto Mining Announce Completion Of Merger
Diplomat Pharmacy Completes Acquisition Of BioRx
Duke Realty Completes $1.1 Bln Suburban Office Portfolio Sale
Intrexon Corp. (XON) announced after the bell Wednesday that it has signed a Cooperative Research and Development Agreement with the National Cancer Institute for the development of adoptive T cell therapies utilizing the RheoSwitch Therapeutic System platform for the treatment of solid tumor malignancies....